Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 cyclopia sequence 6 Prostatic Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Fatigue 2 Warts 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Intraepithelial Neoplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Papilloma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuromyelitis Optica 1 Myelitis, Transverse 1 Myelitis 1 Melanoma 1

Interventions

Surveys and Questionnaires 4 Dexamethasone 2 Calcium Dobesilate 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tiotropium Bromide 1 Sugars 1 Respiratory Therapy 1 Oxygen 1 Midazolam 1 Lisinopril 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Dyspnea × Sugars × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡